Results 171 to 180 of about 18,838 (319)

Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This study evaluated long‐term safety and efficacy in patients with moderate‐to‐severe atopic dermatitis. Patients with and without previous nemolizumab experience received nemolizumab 30 mg Q4W plus TCS/TCI. Nemolizumab was well‐tolerated through 104 weeks with clinically meaningful improvements in disease signs and symptoms.
Matthias Augustin, Marie Tauber, Robert Sidbury, Jonathan I. Silverberg, Kim A. Papp, Diamant Thaçi, Marjolein S. De Bruin‐Weller, Adam Reich, Ketty Peris, Kirk Barber, Ryszard Galus, Andrzej Kaszuba, Matthew Zirwas, Walter K. Nahm, Gretel Trullenque, Laura Maintz, Sady Alpizar, Sang Wook Son, Vivian Laquer, Linda Stein Gold, Soo Yeon Cheong, Anna Ryzhkova, Agnes Drahos, Liliana Ulianov, Christophe Piketty   +24 more
wiley   +1 more source

Effects of Topical Corticosteroid and Tacrolimus on Ceramides and Irritancy to Sodium Lauryl Sulphate in Healthy Skin [PDF]

, 2011
Agner, Tove, Hellgren, Lars, Høgh, Julie Kaae, Jemec, Gregor B.E., Jungersted, Jakob Mutanu   +4 more
core   +1 more source

Biomarker-Based Diagnosis of Contact Dermatitis: A Step Towards More Accurate and Patient-Friendly Testing. [PDF]

Clin Pract
Grob N, Rustemeyer T, de Boer F.
europepmc   +1 more source

Recurrent Flexural Pellagroid Dermatitis: An Unusual Variant of Irritant Contact Dermatitis

, 2015
Ruth Segal, Marina Eskin‐Schwartz, Akiva Trattner, Meora Feinmesser, Emmilia Hodak, A Ingber, Matthias David   +6 more
openalex   +1 more source

Cement Irritant Contact Dermatitis in a Construction Helper. An Occupational Medicine Case Report

, 2022
Mohammad Fadhito Firmansyah, Kasyunnil Kamal, Dewi Sumaryani Soemarko, Dewi Yunia Fitriani   +3 more
openalex   +1 more source

The exposomal imprint on rosacea: More than skin deep

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Rosacea reflects systemic and environmental interactions, not just a skin disorder. Key factors include environmental triggers, genetic and microbiome influences, diagnostic gaps in skin of colour and social determinants. Advances in multi‐omics and exposome integration highlight pathways towards precision medicine, prevention and equitable, patient ...
Katerina Grafanaki, Daniella Bakoli Sgourou, Alexandros Maniatis, Efstathia Pasmatzi   +3 more
wiley   +1 more source

Mask-Induced Dermatitis Progressing to Chronic Seborrheic Inflammation: A Case Report. [PDF]

Cureus
Bin Rakan M, Rakan M, Bin Rakan I.
europepmc   +1 more source

Homoeopathic intervention in corticosteroid-resistant contact irritant dermatitis: A case report

A Prajisha
openalex   +1 more source

Therapeutic advances in pruritus as a model of personalized medicine

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Recent advances in itch biology reveal that chronic pruritus arises from distinct neuroimmune pathways driven by cytokines, JAK, BTK and GPCRs. Targeted biologics and small molecule inhibitors such as dupilumab, nemolizumab, remibrutinib and JAK inhibitors precisely modulate these pathways, leading to a new era of personalized therapeutics in pruritus.
Kelsey Auyeung, Ramsey Kubofcik, Brian S. Kim   +2 more
wiley   +1 more source

Allergic contact dermatitis and irritant contact dermatitis from medical devices used by patients with insulin‐dependent diabetes mellitus [PDF]

Katlein França, JiaDe Yu
openalex   +1 more source